Laser or drops? new study tests best first move for glaucoma
NCT ID NCT07310719
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two first-line treatments for primary open-angle glaucoma or high eye pressure: a one-time laser procedure (selective laser trabeculoplasty) versus daily latanoprost eye drops. Researchers will track how well each lowers eye pressure and note any side effects over three months. The goal is to see if the laser is a safe and effective alternative to daily drops for Nigerian patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Selective laser trabeculoplasty (laser procedure) and latanoprost eye drops
- What this could lead to
- If successful, this could show that a one-time laser procedure is as safe and effective as daily eye drops for controlling eye pressure in glaucoma patients.
- What could go wrong
- This is a small, short-term study (138 patients, 3 months) in a single hospital, so results may not apply broadly. The laser may not lower pressure enough, or side effects could differ from drops.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Lagos State University teaching Hospital Eye Institute
RECRUITINGIkeja, Lagos, Nigeria
More trials for these conditions
Other studies related to the condition(s) this trial covers.